Novo Nordisk Shares Should Recover Ground After Friday's Overreaction
Shares in Novo Nordisk opened higher in Europe, partially recovering some of Friday’s heavy losses, but analysts were mixed on the prospects for its experimental weight-loss drug CagriSema.
Shares in Novo Nordisk opened higher in Europe, partially recovering some of Friday’s heavy losses, but analysts were mixed on the prospects for its experimental weight-loss drug CagriSema.
What's Your Reaction?
